Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 6 | $7,402,885 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 05 Sep 2024 11:53 | RARE | Ultragenyx Pharmaceutical Inc | KAKKIS EMIL D | President & CEO | 03 Sep 2024 | Sale | 20,000 | 55.85 | 1,117,000 | I |
| 07 Aug 2024 14:48 | RARE | Ultragenyx Pharmaceutical Inc | KAKKIS EMIL D | President & CEO | 06 Aug 2024 | Sale | 20,000 | 50.17 | 1,003,400 | I |
| 08 Feb 2024 15:49 | RARE | Ultragenyx Pharmaceutical Inc | KAKKIS EMIL D | President & CEO | 07 Feb 2024 | Sale | 30,000 | 45 | 1,350,000 | D |
| 02 Jan 2024 16:07 | RARE | Ultragenyx Pharmaceutical Inc | KAKKIS EMIL D | President & CEO | 29 Dec 2023 | Sale | 30,000 | 47.87 | 1,436,100 | D |
| 23 Oct 2023 17:14 | RARE | Ultragenyx Pharmaceutical Inc | KAKKIS EMIL D | President & CEO | 19 Oct 2023 | Sale | 47,853 | 33.52 | 1,604,033 | D |
| 03 Jan 2023 16:45 | RARE | Ultragenyx Pharmaceutical Inc | KAKKIS EMIL D | President & CEO | 30 Dec 2022 | Sale | 19,582 | 45.57 | 892,352 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)